PolyNovo has been granted access to the US Department of Defence (DoD) contracts through a Defence Acquisition and Program Administration (DAPA) and Veteran's Affairs (VA) contract. This access allows DoD facilities to purchase NovoSorb BTM for the treatment of serving military, veteran's, and their families. DoD health facilities, anywhere in the world, will now be able to purchase NovoSorb BTM. In addition, PolyNovo has been granted access to several other United States Government contracts. The US Government will provide BTM access to Medicare/Medicaid patients under the Federal Supply Services (FSS) contract. Importantly, this enables both inpatient and outpatient treatments using BTM to be reimbursed.